Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML)
Vol. 32 No. 3 (2026)

The Value of Cardiac Troponin I and Midkine in Predicting Coronary Artery Obstruction Severity in Chronic Coronary Syndromes (CCS)

Moayed Basheer Hamid (Interventional Cardiologist Department of Medicine, College of Medicine, Al-Nahrain University, Baghdad)
Amal Abbas Hammoodi (Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad)
Basil Oied Mohemed Salih (Department of Clinical Biochemistry, College of Medicine, University of Baghdad, Baghdad)
Ameen Al-Alwany (College of Medicine, University of Baghdad, Baghdad)



Article Info

Publish Date
27 Jul 2026

Abstract

High-sensitive cardiac troponin I (hs-cTnI) is a recognized marker of myocardial injury in acute coronary syndromes, but its utility in chronic coronary syndromes (CCS) remains unclear. Midkine (MK), a heparin-binding growth factor, plays a role in inflammation and vascular remodeling in atherosclerosis. This cross-sectional study aimed to evaluate the predictive value of serum hs-cTnI and MK in determining the severity of coronary artery obstruction in patients with CCS. The study included 125 subjects undergoing coronary angiography (CAG) at the Iraqi Center of Heart Disease/ Medical City/Baghdad, from March to December 2024. Subjects were classified into three groups based on CAG findings: no CAD, 1- or 2-vessel disease, and 3-vessel or left main disease. Serum levels of hs-cTnI and MK were measured using enzyme-linked immunosorbent assay (ELISA) in the laboratories of Department of Biochemistry/College of Medicine/ Baghdad University. Median serum levels of both biomarkers differed significantly across all groups. Receiver operating characteristic curve analysis demonstrated good diagnostic performance for both biomarkers in differentiating moderate (Group II) from severe disease (Group III). For hs-cTnI, a cutoff of 354.4 pg/mL yielded 90% sensitivity and 92% specificity; for MK, a cutoff of 2.75 ng/mL yielded 90% sensitivity and 85% specificity. Logistic regression revealed that the two biomarkers together explained 75% of the variance in CAD severity. Combining the two markers offered a slight improvement in diagnostic accuracy compared to using either alone. In conclusion, serum hs-cTnI and MK levels may help predict CAD severity in CCS and support early risk stratification before CAG.

Copyrights © 2026






Journal Info

Abbrev

patologi

Publisher

Subject

Biochemistry, Genetics & Molecular Biology Health Professions Medicine & Pharmacology Neuroscience

Description

Indonesian Journal of Clinical Pathology and Medical Laboratory (IJCPML) is a journal published by “Association of Clinical Pathologist” professional association. This journal displays articles in the Clinical Pathology and Medical Laboratory scope. Clinical Pathology has a couple of ...